Abstract
There are as yet no common standards regarding lymph node dissection during tumor nephrectomy. In order to assess prognoses and survival rates and ensure early detection of kidney tumors, a pathohistological staging following lymphadenopathy and new adjuvant therapies in metastatic disease have to be established in the future. The aims of lymph node dissection are - as far as the morbidity and performance status of the patient are concerned - accurate staging and a decrease in risk of tumor recurrence, particularly in organ-confined cancer disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
